| Literature DB >> 20026598 |
Fatemeh Fouladkou1, Chen Lu, Chong Jiang, Limei Zhou, Yimin She, Jonathon R Walls, Hiroshi Kawabe, Nils Brose, R M Henkelman, Annie Huang, Benoit G Bruneau, Daniela Rotin.
Abstract
Nedd4 (Nedd4-1) is a Hect domain E3 ubiquitin ligase that also contains a C2 domain and three WW domains. Despite numerous in vitro studies, its biological function in vivo is not well understood. Here we show that disruption of Nedd4-1 in mice (leaving Nedd4-2 intact) caused embryonic lethality at mid gestation, with pronounced heart defects (double-outlet right ventricle and atrioventricular cushion defects) and vasculature abnormalities. Quantitative mass spectrometry and immunoblot analyses of lysates from the wild type and knock-out mouse embryonic fibroblasts to identify Nedd4-1 in vivo targets revealed dramatically increased amounts of thrombospondin-1 (Tsp-1) in the knock-out mouse embryonic fibroblasts and embryos. Tsp-1 is an inhibitor of angiogenesis, and its elevated level was mediated primarily by enhanced transcription. Interestingly, the administration of aspirin (an inhibitor of Tsp-1) to the pregnant heterozygote mothers led to a reduction in Tsp-1 levels and a substantial rescue of the embryonic lethality. These results suggest that Nedd4-1 is a suppressor of Tsp1 and that increased levels of Tsp-1 in the Nedd4-1 knock-out mice may have contributed to the developmental defect observed in the embryos.Entities:
Mesh:
Substances:
Year: 2009 PMID: 20026598 PMCID: PMC2825471 DOI: 10.1074/jbc.M109.082347
Source DB: PubMed Journal: J Biol Chem ISSN: 0021-9258 Impact factor: 5.157